Stocktoria
ENDRA Life Sciences Inc. NDRA
Nasdaq · XNAS · stock · Electromedical & Electrotherapeutic Apparatus · website · IPO 2017-06-28
ENDRA Life Sciences Inc. statistics & valuation
Market cap$6.3M
P / B2.8×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -182.4% | -258.5% | -148.9% | -142.1% | -87.2% |
| Return on equity | -310.9% | -449.5% | -177.8% | -182.9% | -104.1% |
| Debt / equity | — | 0.00× | 0.00× | 0.00× | 0.05× |
| Current ratio | 1.29 | 5.67 | 3.36 | 3.16 | 7.83 |
Source: SEC EDGAR filings · CIK 0001681682 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.